Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

429 – A Novel Immunotherapeutic Platform for Amplifying HIV, CMV, or SARS-CoV-2-Specific T-Cell Responses

Background While adoptive cell transfer of HIV-specific T cells is a promising immunotherapy to provide a functional cure for HIV, its development and broader application is limited by the cost, logistical complexity, and variability of current methods for ex vivo expansion of HIV-specific T cells. To address these needs, we describe a novel modular and…

455 – Cannabidiol Has Sex-Dependent Anti-Inflammatory Effects in Long-Term Suppressed HIV-1 Adults

Background People with long-term HIV-1 suppression (PWH) suffer from inflammaging, characterized by chronic inflammation and immunosenescence. As cannabis smokers display immune beneficial effects such as lower inflammation levels we decided to investigate the anti-inflammatory properties of one of its major component, the cannabidiol (CBD) under a full-spectrum oil, on PWH. Methods Within the double-blind, randomized,…

406 – HIV-Infection Does Not Generally Confer Higher Resistance to CTL-Mediated Lysis

Background While current antiretroviral treatment regimens can reliably prevent new infection events in people living with HIV (PLWH), they cannot actively eliminate the persistent population of CD4 T cells harboring intact provirus that can give rise to viral rebound if treatment is interrupted. Various approaches to HIV cure rely on the elimination of this reservoir…

475 – Long COVID Is Associated With Lower Percentages of Mature, Cytotoxic NK-Cell Phenotypes

Background Long COVID (LC) is associated with dysregulated adaptive immune function and inflammation, which may originate from or contribute to the persistence of SARS-CoV-2 in post-acute COVID-19. COVID-19 can also induce adaptive NK cell responses during the acute phase, but our understanding of NK cell phenotypes in the post-acute phase and their relationship to LC…

416 – Maturation of B-Cell Lineages During cART in Chronic SHIV-Infected Juvenile Rhesus Macaques

Background HIV-1 infection alters the frequencies and functions of B cell subsets, which may be restored by combined antiretroviral therapy (cART). There is still a gap in our knowledge that limits our understanding of the maturation of autologous HIV-1 neutralizing antibodies (NAbs) during cART. Our goal was to interrogate the dynamics of B cell lineages…

408 – HIV-1-Specific T Cells From Post-Treatment Controllers and Noncontrollers

Background Understanding the immune response to HIV-1 in individuals maintaining long-term viral suppression after analytical treatment interruption (ATI) is crucial in the search for a functional cure. A subset of individuals, post-treatment controllers (PTCs), experience sustained virologic control following ATI, whilst non-controllers (NCs) require re-initiation of antiretroviral therapy (ART) to suppress rebounding viremia. We investigated…

404 – TCR Convergence in HIV Controllers: Insights Into Natural Viral Suppression

Background HIV controllers are rare individuals who suppress viral replication without antiretroviral therapy (ART). We hypothesized that this might partly be driven by T-cell receptor (TCR) convergence, a phenomenon where different DNA sequences encode identical amino acids. TCR convergence may indicate antigen-driven selection, reflecting a more focused immune response. This study applies a novel method…

474 – Optimized ACE2-Fc With Picomolar Pan-Neutralization of SARS-CoV-2 Variants, Including JN.1 and KP.2

Background Many neutralizing monoclonal antibodies capable of providing sterilizing immunity against SARS-CoV-2 have been developed and temporarily approved for emergency clinical use as prophylactics. However, the rapid evolution of SARS-CoV-2 progressively renders these treatments obsolete. Several groups have been exploring the use of ACE2-based Fc fusion proteins to obtain a pan-variant neutralizing molecule. In this…

383 – The Systemic Inflammatory Profile Differs According to the Mechanism of HIV Control

Background Elite controllers (EC) are an exceptional group of people living with HIV (PLWH) able to control HIV replication without antiretroviral therapy and have been proposed as a model of functional HIV cure. However, significant evidence suggests that despite viral control, EC subjects may have altered levels of activation and systemic inflammation. We have characterized…

472 – Diminished Immune Imprinting at the Upper Respiratory Tract Following SARS-CoV-2 Breakthrough Infection

Background Immune imprinting, also known as original antigenic sin, refers to the effects prior exposures have on subsequent immunity against antigenically related viruses. The immune imprinting of humoral immunity at anatomic sites of the respiratory tract following SARS-CoV-2 breakthrough infection is not well understood.  Methods Ninety-six adult donors with COVID-19 vaccination and breakthrough infection (BTI)…